跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
SHINGRIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA
Approved
STANDARD
SHINGRIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA
Glaxosmithkline Biologicals
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 10, 2026
Approval ID
89df14adc5dcdd7b
Company
Glaxosmithkline Biologicals
Type
Standard
Approval Details
Approval Id
89df14adc5dcdd7b
Drug Cima Aemps Name
SHINGRIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA
Register Number
1181272003
Holder Company Name
Glaxosmithkline Biologicals
Marketing Company Name
Glaxosmithkline S.A.
Holder Company Detail Path
/organization/glaxosmithkline-biologicals
Marketing Company Detail Path
/organization/glaxosmithkline-sa
Authorization Date
2026-09-10
Dosage Form
SUSPENSIÓN INYECTABLE EN JERINGA PRECARGADA
Dose
50 microgramos
Route Of Administration
VÍA INTRAMUSCULAR
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Glaxosmithkline Biologicals
Company Detail Path
/organization/glaxosmithkline-biologicals
Company Information
Pharmaceutical Company Name
GLAXOSMITHKLINE BIOLOGICALS
Country Name
France
City Name
st amand les eaux,hauts de france,country_fr
Address
637 RUE DES AULNOIS
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 10, 2026
Approval ID
89df14adc5dcdd7b
Type
Standard
Back to CIMA-AEMPS Approvals
SHINGRIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA - CIMA-AEMPS Drug Approval Details
